Skip Navigation

Correction for Poulos et al., Cardiovasc Res 55 (2) 238.
Cardiovascular Research 1996 32(5):909-919; doi:10.1016/S0008-6363(96)00138-1
© 1996 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Corrigendum (v55,p238)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Poulos, J. E.
Right arrow Articles by Vesely, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulos, J. E.
Right arrow Articles by Vesely, D. L.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1996, European Society of Cardiology

Congestive heart failure: increased cardiac and extracardiac atrial natriuretic peptide gene expression

John E. Poulosa,b,1, William R. Gower, Jr.a,b, J.Thompson Sullebargera,b, Hector L. Fontaneta,b and David L. Vesely*,a,b

aDepartments of Biochemistry and Molecular Biology, Internal Medicine, Physiology and Biophysics, James A. Haley Veterans Hospital Tampa, FL 33612, USA
bUniversity of South Florida Health Sciences Center, Tampa FL 33612, USA

* Corresponding author, at: J.A. Haley Veterans Hospital-151, 13000 Bruce B. Downs Blvd., Tampa, FL 33612, USA. Tel. (+1-813) 972 7624; Fax (+1-813) 972 7623.

Objectives: The present investigation was designed to determine if atrial natriuretic peptide (ANP) gene expression increases in extracardiac as well as within the heart in congestive heart failure. Methods: Congestive heart failure (CHF) was induced by producing cardiac hypertrophy secondary to an aortocaval fistula in Sprague-Dawley rats. To characterize this model, control and CHF rats had cardiac catheterizations and transthoracic echocardiography. ANP messenger RNA was measured by RNAase protection analysis in atria, ventricles, liver, colon, and stomach of CHF and sham rats and quantitated by 2-D scanning. The product of ANP gene expression was determined in each of these tissues with high performance-gel permeation chromatography. To help determine if increased degradation of atrial natriuretic peptides occur in congestive heart failure, the circulating concentrations and the excretion of the atrial natriuretic peptides into urine were measured by specific radioimmunoassays. Results: ANP steady-state mRNA increased 4.2 ± 0.05 and 4.3 ± 0.06-fold, respectively, in the antrum of the stomach and within the heart ventricle of CHF rats compared with age-matched sham rats. ANP gene expression was present but not increased in atria, liver, and gastrointestinal tract of the CHF rats. High-performance gel permeation chromatography revealed that the product of this ANP gene expression within the stomach and heart ventricle in CHF animals was the ANP prohormone. There was not any decrease in the metabolism of these peptides; by the kidney in CHF. Conclusions: ANP steady-state mRNA increases in extracardiac (i.e., stomach antrum) tissue as well as in the ventricle of the heart in CHF. The product of the ANP gene expression, i.e., the ANP prohormone is the same in the extracardiac tissues as within the heart. Whether the increased extracardiac ANP steady-state mRNA and its resultant increased atrial natriuretic peptides helps prevent bowel wall edema in CHF needs to be elucidated.

KEYWORDS Atrial natriuretic factor; Gene expression; Heart failure; Rat, A-V fistular model


1 Present address: St. Louis Medical Center, 3635 Vista Ave. at Grand Blvd., P.O. Box 15250, St. Louis, MO 63110-0250, USA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

Congestive heart failure: increased cardiac and extracardiac atrial natriuretic peptide gene expression
John E Poulos, William R Gower, Jr., Thompson Sullebarger, Hector L Fontanet, and David L Vesely
Cardiovasc Res 2002 55: 238. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. J Janse
An odyssee of figures or the importance of proofs
Cardiovasc Res, August 1, 2002; 55(2): 236 - 237.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. L Vesely
Atrial natriuretic peptides in pathophysiological diseases
Cardiovasc Res, September 1, 2001; 51(4): 647 - 658.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Daggubati, J. R Parks, R. M Overton, G. Cintron, D. D Schocken, and D. L Vesely
Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
Cardiovasc Res, November 1, 1997; 36(2): 246 - 255.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.